Head to head
REX American Resources vs Dow Inc
Side-by-side on the measures that matter, with a plain-English read. Full detail: REX · DOW
REX
REX American Resources
44.31+0.61%
1-year price shape — +41% over the period
Quant Rating B · 77/100
vs
DOW
Dow Inc
27.77-1.38%
1-year price shape — +29% over the period
Quant Rating D · 66/100
1-year performance, rebased to 100
REX American Resources edges it on the scoreable measures. REX American Resources has the highest Quant Rating (77); REX American Resources has done best over the past year (+41%); REX American Resources earns the most per share.
| REX | DOW | |
|---|---|---|
| Snapshot | ||
| Sector | Chemicals | -- |
| Last price | 44.31 | 27.77 |
| Change today | +0.61% | -1.38% |
| 1-year return | +40.9% | +29.4% |
| Market cap | $1.47B | $20.06B |
| 52-week range | 30.46 – 53.36 | 19.91 – 41.82 |
| Valuation | ||
| P/E (TTM) | 12.14 | -15.17 |
| P/E percentile, own 5-yr range | 30th | 11th |
| P/B | 2.18 | 1.26 |
| Dividend yield | 0.00% | 5.04% |
| Profitability & growth | ||
| EPS (TTM) | 2.50 | -3.70 |
| Net profit (TTM) | $82.94M | $-2.67B |
| Revenue (TTM) | $658.58M | $41.32B |
| Revenue growth (YoY) | +6.3% | +19.7% |
| Gross margin | 22.4% | 9.9% |
| Operating margin | 15.4% | 3.7% |
| Net margin | 18.3% | -3.1% |
| Free cash flow (TTM) | $68.55M | $1.60B |
| Ownership & sentiment | ||
| Institutional ownership | 80.9% | 79.4% |
| Insider activity (12mo) | 26 buy / 24 sell | 38 buy / 9 sell |
| Short interest (% of float) | 2.9% | 4.9% |
| Analyst consensus | -- | 33% buy / 58% hold / 8% sell (12) |
| Analyst price target | -- | $35 (+25%) |
| StockVane view | ||
| StockVane Quant Rating | B (77) | D (66) |
| Company | ||
| Employees | 132 | 34,600 |
| Founded | 1984 | 1897 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.